Regenerating articular cartilage and fibrocartilaginous tissue such as the meniscus is still a challenge in orthopedic medicine. While a range of different scaffolds have been developed for joint repair, none have facilitated the development of a tissue that mimics the complexity of soft tissues such as articular cartilage. Furthermore, many of these scaffolds are not designed to function in mechanically challenging joint environments. The overall goal of this study was to develop a porous, biomimetic, shape-memory alginate scaffold for directing cartilage regeneration.
Introduction
Articular cartilage it is a highly specialized anisotropic tissue that functions to support joint contact forces and to reduce friction within the joint (1, 2) . Regenerating this complex tissue is still a challenge in the field of orthopedic medicine, due in part to its avascular nature (3, 4) . Chondral and osteochondral lesions often result in pain and swelling, followed by further joint degeneration and eventually osteoarthritis (3, 4) . Injuries to cartilage can be treated with a range of approaches, including marrow stimulation techniques (5), mosaicplasty (6) and cell-based therapies (3, 7) such as autologous chondrocyte implantation (ACI) (8) , matrix-induced autologous chondrocyte implantation (MACI) (9) or the use of adult stem cells (10) . Similar challenges exist when trying to regenerate other joint tissues such as the meniscus (11) . In the context of both articular cartilage and meniscus regeneration, novel scaffolds are required that are not only mechanically robust and compatible with the load bearing environment of a synovial joint, but which can also direct progenitor cells down the chondrogenic or fibro-chondrogenic pathway and promote the development of an organized tissue.
Porous scaffolds for cartilage tissue engineering can be fabricated using different rawmaterials and manufacturing techniques (10, 12, 13, 14) . Ideally these biomaterials should be instructive to cells that are seeded or recruited into the scaffold (10, 15) . Native extracellular matrix (ECM) (16, 17) and it derivatives such as collagen (18, 19) and hyaluronic acid (20) , as well as other natural polymers such as chitosan (21, 22) and alginate (23) (24) (25) (26) , are commonly used as biomaterials in cartilage tissue engineering. Furthermore, inert biomaterials can be functionalized to promote chondrogenesis through the incorporation of cartilage specific ECM components such as type II collagen (21, 22, (27) (28) (29) . Alginate is a relatively inert polysaccharide that is commonly used as a biomaterial in the field of tissue engineering (10, 25) . Highly porous shape-memory scaffolds can be produced by covalently crosslinking alginate using carbodiimide chemistry (23, 24, 30) . Such scaffolds can be compressed to a fraction of their original height and then return to their initial shape when rehydrated (30). A potential limitation with these scaffolds is poor cellular infiltration and attachment, although this can be improved through the incorporation of different 4 ECM components, such as fibronectin (31) or collagen (24) . The unique mechanical properties of these shape-memory alginate scaffolds make them highly attractive for implantation into load bearing environments such as synovial joints, however their structure and composition must firstly be optimized for promoting chondrogenesis and the development of an organized tissue.
It is known that tissue architecture plays a key role in native tissue function and in its mechanical performance (14) . Musculoskeletal tissues are highly anisotropic, with a composition and structure optimized to enable performance in highly loaded environments (1, 2) . The structure of native tissues has inspired scaffold designs with aligned pore geometries to direct cell and neotissue alignment (32-36). It is possible to produce aligned scaffolds by using different methods such as ionotropic gelation (31, 37), 3D bioprinting (38), electro-spinning (39, 40) and directional freezing (32, 33, 36). Using a directional freezing method, pore alignment can be modulated by changing the angle of the freezing surface, which in turn determines the direction of ice crystal growth (32). Such unidirectional techniques can enable the fabrication of scaffolds with an anisotropic architecture and improved mechanical properties (32, 33, 41, 42).
The overall goal of this study was therefore to develop a porous, biomimetic, shapememory alginate scaffold for directing either articular cartilage or meniscal cartilage regeneration.
In order to explore how scaffold pore geometry can influence cellular recruitment and direct cellular and neo-cartilage tissue alignment, scaffolds with both isotropic (non-aligned) and anisotropic (aligned) pore geometries were produced using traditional and unidirectional freeze-drying techniques. These scaffolds were then functionalized with the addition of either type I collagen, type II collagen or chondroitin sulfate (CS). The capacity of these scaffolds to support the development of either hyaline cartilage or fibrocartilage was then assessed in vitro by seeding with human infrapatellar fat pad-derived stem cells and stimulating these constructs with transforming growth factor-β3. Our hypothesis was that type I collagen functionalization would promote the development of meniscal cartilage (fibrocartilage), while type II collagen functionalization would promote the development of a more hyaline-like articular cartilage tissue.
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Material and methods
Preparation of covalently crosslinked alginate scaffolds
Fabrication of alginate scaffolds with isotropic (non-aligned) pore geometries
Alginate scaffolds with isotropic (non-aligned) pore geometries (Non-Al) were fabricated using a previously reported protocol (23, 24) . Sodium alginate (Pronova UP LVG; Novamatrix, Sandvika, Norway) was covalently crosslinked using carbodiimide chemistry (23, 24) . In brief, the polymer was dissolved in 2-(N-Morpholino) ethanesulfonic acid buffer (MES; pH 6.0 at 0.1 M) with NaCl (0.2 M), to a final concentration of 3.3% (w/v). Solutions of N-Hydroxysuccinimide (NHS) and 1-ethyl-3-3dimethyl aminopropyl carbodiimide (EDAC) were homogenized with alginate solution (5 minutes) with a final molar ratio of 2:1:2 for EDAC:NHS:COO -. Furthermore, a crosslinking agent, adipic acid dihydrazide (AAD) (all chemicals from Sigma-Aldrich), was added to the solution (molar ratio of 45% compared to alginate n NH2 /n COOH ), quickly homogenized and transferred into a mould.
The reaction was performed overnight at room temperature. Finally, the alginate hydrogel was washed several times in ultrapure water (UPW) for 24 hours to remove unreacted chemicals. After the washing step, cylinders (5 mm in diameter and 3 mm in height) of the hydrogel were cored out from the main hydrogel slab using a biopsy punch (5 mm). To create porous scaffolds, a freezedrying process was used (23, 24, 43) . Briefly, hydrogels were placed in a Petri dish on the cooling shelf of a laboratory freeze-dryer (Labconco Triad TM , Kansas City, MO, USA) and frozen to -30°C (1°C min -1 ) and maintained at that temperature for 1 hour. The temperature was then increased under vacuum (0.2 mBar) to -10 °C (1°C min -1 ) and held for 24 hours, before being increased to room temperature (0.5°C min -1 ).
Fabrication of alginate scaffolds with anisotropic (aligned) pore geometries
Alginate scaffolds with anisotropic aligned pore geometries (Align) were fabricated using a modified version of a previously described unidirectional freezing technique (32-34). A 20 mm thick stainless steel plate was cooled in liquid nitrogen, cylindrical alginate hydrogels as described above were dropped vertically onto the cold flat metal surface. Frozen blocks were transferred 6 quickly with tweezers onto a pre-cooled (-30°C) freeze-dryer shelf and the drying process was performed in the same manner as for Non-Al scaffolds.
Functionalization of alginate scaffolds with ECM components
The Align scaffolds were further functionalized with either type I collagen, type II collagen or CS. Type I collagen was obtained from a commercial source (extracted from rat tail, BD Biosciences, Oxford, United Kingdom). Type II collagen (collagen content of 95%±4%) was isolated from bovine knees and hocks using a previously reported protocol (44) (45) (46) . Briefly, bovine joints were obtained locally and washed thoroughly with 70% alcohol. Cartilage slices were removed from the joints using a scalpel and minced into small pieces (1-2 mm). Sterile filtered NaOH (0.2M) was added to cartilage pieces (1ml per 50mg) and rotated for 24 hours at 4°C. The suspension was centrifuged (2500 g; 10 min; 4°C) and the supernatant discarded (repeated 3 times). Cartilage pieces were re-suspended in activated pepsin solution (1500 U ml -1 ) at a ratio of 1ml per 50mg of tissue. The suspension was homogenized vigorously and incubated on a rotating platform for 24 hours (20°C; 4 rpm). The solution was centrifuged (2800g; 1hr; 4°C) and the supernatant transferred to a tube. Sterile filtered NaCl (5M) was slowly added into the tube in order to obtain a final concentration of 0.9M NaCl. The solution was homogenized and allowed to equilibrate overnight (4°C). Thereafter, the mixture was centrifuged, the supernatant discarded and the pellet washed with UPW. Collagen was re-suspended in sterile filtered acetic acid (10 ml; 0.5M) and allowed to solubilize overnight (T<20°C; 4 rpm). Acidic solubilized collagen was transferred to a previously prepared dialysis membrane (MWCO; 10 kDa) and dialyzed with mild rotation against 0.02 M Na 2 HPO 4 (pH 9.4) for 24 hours at 4°C with two exchanges. Dialyzed collagen solution was freeze-dried and stored in a freezer at -20°C until use. All chemicals were obtained from Sigma-Aldrich.
Scaffolds were functionalized by either coating the scaffold with collagen, adapted from a previously reported protocols (24, 47, 48) , or blending collagen into the alginate prior to scaffold production. For coated scaffolds functionalized with type I (C1C) and type II (C2C) collagen, collagen solutions were prepared (0.05% w/v) in 0.5M acetic acid. After freeze-drying the alginate, 7 coated scaffold was then freeze-dried a second time using the same protocol. For the blended scaffolds, type I (C1B) and II (C2B) collagen was mixed with the initial alginate solution at a concentration of 0.05% (w/v) of collagen in the total volume. Aligned scaffolds were additionally coated with chondroitin sulfate (Sigma-Aldrich) as a further control for functionalization. The subsequent freeze-drying steps were the same as that for the non-functionalized Align scaffold.
Assessment of mechanical properties
Scaffolds were mechanically tested as previously described using a standard materials testing machine with a 5 N load cell (Zwick Z005, Roell, Germany) (24, 43, 49) . For day 0 and day 28, a preload of 0.01 N was applied to ensure direct contact between the scaffold or construct and the loading platens. Stress relaxation tests were performed, in which a ramp and hold cycle (displacement of 1 mm/s until 10% strain) was obtained and maintained until equilibrium was reached. The compressive equilibrium modulus was determined by dividing the stress determined at equilibrium by the applied strain (10%). To assess the shape-memory properties of the scaffolds, the same compressive test to 10% strain was applied before and after the application of fifty compressive cycles of 10% strain. All compressive tests were unconfined and with scaffolds or constructs maintained in PBS.
As a macroscopic assessment of their shape-memory properties, tweezers was used to compress the scaffolds. Images taken before and after compression were used to assess the ability of scaffolds to recover their original geometry.
SEM imaging of scaffolds
Alginate scaffolds were imaged using scanning electron microscopy (SEM) as previously described (24) . Briefly, scaffolds were fixed in paraformaldehyde solution (4%) overnight followed by several phosphate buffed saline (PBS) washings. Scaffolds were dehydrated through successive graded ethanol baths (10-100%), fixed onto aluminum stubs, coated with gold and examined under a field emission SEM (Tescan Mira FEG-SEM XMU, Libušina, Czech Republic).
Images were analyzed with Image J to quantify mean pore size. For in vitro studies, 5x10 5 culture expanded human IFP-derived stem cells (FPSCs) were seeded onto alginate scaffolds. Before seeding, scaffolds were sterilized in 70% ethanol (30 minutes) followed by washes in sterile PBS (52) . Next, the alginate/cell constructs were maintained in chemically defined chondrogenic medium (CDM), as previously described (43, ), insulin-transferrin-selenium (1x), dexamethasone (100 nM) (all from Sigma-Aldrich, Ireland) and recombinant human transforming growth factor-β3 (TGF-β3, 10 ng ml
; ProSpecTany TechnoGene Ltd, Israel). Constructs were contained within cylindrical agarose moulds 9 cultured in 12 well plates. Cells were allowed to attach for two hours, followed by supplementation with 2.5ml of CDM. Complete media changes were performed twice weekly.
Biochemical analysis
Alginate constructs were biochemically analyzed at day 28, for DNA, sulphated glycosaminoglycans (sGAG) and collagen content, as previously described (23, 24, 43) . Briefly, constructs were enzymatically digested with papain (125 μg ml -1 ) in sodium acetate (0.1 M), cysteine-HCl (5 mM), Ethylenediaminetetra-acetic acid (EDTA) (0.05 M), pH 6.0 (all from SigmaAldrich) at 60˚C under rotation (10 rpm; 18 hours). DNA content of each sample was quantified using the Hoechst Bisbenzimide 33258 dye assay, with a calf thymus DNA standard as previously described (23, 24) . Proteoglycan content was estimated by quantifying the sGAG in constructs using the dimethylmethylene blue dye-binding assay (Blyscan, Biocolor Ltd., Northern Ireland), using a bovine chondroitin sulfate standard (23) . Collagen content was quantified by measuring hydroxyproline content, after acidic hydrolysis of the samples (110°C; 18 hours) in concentrated HCL (38%) (23, 24, 43) . Samples were assayed using a chloramine-T assay assuming a hydroxyproline/collagen ratio of 1:7.69 (50).
Histology and immunohistochemistry
Alginate constructs were fixed overnight (4˚C) in paraformaldehyde (4%), followed by washing in PBS, dehydrated and wax embedded. Wax embedded constructs were sectioned to produce 6 µm thick slices and mounted on microscope slides. Day 0 acellular Non-Al and Aligned sections were stained with 1% alcian blue 8GX (Sigma-Aldrich) in HCl (0.1 M) for sGAG to examine scaffold structure and material distribution. With the aim of monitoring cell colonization and the newly formed matrix, constructs were histologically analyzed through staining with aldehyde fuchsin (AF)-alcian blue, and haematoxylin and eosin (H&E) at day 0 and 28, using previously mentioned protocols for alginate scaffolds (23, 51) . Immunohistochemical analysis was performed on 6 µm sections using monoclonal antibody to type II collagen (Abcam, UK) as previously described (23, 24, 52, 54 ; 1 hour; Anti-Mouse IgG Biotin antibody produced in goat) followed by incubation with ABC reagent (Vectastain PK-400, Vector Labs, UK) for 45 min. Color was developed using the Vectastain ABC reagent followed by exposure to peroxidase DAB substrate kit. Samples were dehydrated with graded ethanol and xylene and mounted with Vectamount medium (Vector Laboratories, UK). Protocols were based in previously described work (23, 24, 43, 54) . Sections were imaged with an Olympus IX51 inverted microscope fitted with an Olympus DP70 camera.
Cell Viability and Actin/DAPI staining
Cell survival and distribution were assessed using a LIVE/DEAD kit (Invitrogen, Bioscience, Ireland) as previously described (24, 43) . Briefly, constructs were washed in PBS, sectioned in half, incubated in calcein (2x10 -6 M; live/green). Segments were washed and imaged using confocal microscopy 10x Olympus FV-1000 Point-Scanning Microscope (Southend-on-Sea, UK) at 515 and 615 nm channels and analyzed using FV10-ASW 2.0 Viewer. 
Statistical Analysis
Results are presented as mean ± standard deviation. Statistical analysis was performed using MINITAB 15.1 software package (Minitab Ltd., Coventry, UK). Experimental groups were analyzed for significant differences using a general linear model (GLM) for analysis of variance (ANOVA) with factors including scaffold architecture, collagen type and functionalization method (i.e. coated or blended). Tukey's test for multiple comparisons was used to compare conditions. Significance was accepted at a level of p<0.05.
Results
Development of a shape-memory alginate scaffold with aligned pores
Shape-memory alginate scaffolds with both a non-aligned (Non-Al) and an aligned (Align) pore structure were produced by freeze-drying covalently crosslinked alginate hydrogels. Scanning electron microscopy (SEM) was used to characterize the morphology and size distribution of the channels/pores in both scaffold types (Figure 1 ). There was no obvious preferred pore alignment in the Non-Al scaffolds ( Figure 1A-C) . Conversely, an aligned honeycomb-like pore architecture was observed in the Align scaffolds ( Figure 1D -F). These differences were also observed upon histological evaluation of the scaffolds ( Figure 1H ). The mean pore diameter for the Non-Al scaffolds was 176±70 μm, while the mean pore/channel diameter for the Align scaffolds was 32±12
μm. Acellular Align scaffolds were stiffer than the Non-Al group ( Figure 1J ). 
Scaffold pore directionality determines stem cell alignment and the extent of extracellular matrix deposition
Both the isotropic (Non-Al) and the anisotropic (Align) scaffolds were then seeded with FPSCs and maintained for up to 28 days in chondrogenic culture conditions. Actin/DAPI staining ( Figure 3A ) was used to assess stem cell alignment in both scaffolds. Viable FPSCs were observed within both scaffolds at day 1, with clustering of cells evident in both groups ( Figure 3A ). By day 10 it was possible to observe new matrix being produced around these clusters of cells ( Figure 3A) . Within the anisotropic (Align) scaffolds, the cells and the matrix they produced was aligned parallel to the pore structure ( Figure 3A) . This organization was also observed in the H&E stained sections of the engineered tissues after 28 days in culture ( Figure 3B ). The composition of the tissues that formed within the scaffolds also depended on the underlying pore geometry, with higher DNA, sGAG and collagen content measured in the Align scaffolds compared to the Non-Al scaffolds after the 4 week culture period ( Figure 3C ). Macroscopically, scaffold anisotropy had a noticeable influence on tissue formation within FPSC seeded scaffolds, with more peripheral tissue deposition within Non-Al scaffolds ( Figure 3D ).
Functionalization of shape-memory alginate scaffolds with either type I or type II collagen
Having demonstrated that aligned scaffolds promote more robust and homogenous tissue deposition within the scaffolds, we next sought to functionalize these anisotropic scaffolds with specific ECM components to further enhance their capacity to support stem cell recruitment and chondrogenesis. Functionalization was performed by either coating the scaffold with collagen and then freeze-drying for a second time, or blending this ECM protein into the alginate prior to freezedrying. Collagen coating was confirmed histologically and using SEM (see supplementary Figure   S1 ). We first sought to determine the impact of such ECM functionalization (type I and II collagen) on the mechanical properties of shape memory alginate scaffolds. This functionalization was only performed on Align scaffolds as they were more chondro-inductive and demonstrated superior mechanical properties (Figure 3 ).
Wet scaffolds were first compressed using a tweezers and again were able to return to their original shape on unloading (Figure 4) . To determine the stability of these ECM functionalized scaffolds, they were next subjected to fifty cycles of compressive strain. Only the type II collagen coated (C2C group) scaffolds demonstrated a significant decrease in mechanical properties (equilibrium modulus) after the application of cyclic loading ( Figure 5 ). However, the stiffness of these C2C scaffolds was still similar to the non-coated (NC) scaffolds after this conditioning phase.
Functionalizing anisotropic shape-memory scaffolds with type II collagen promotes stem cell infiltration and homogenous cartilage tissue deposition
FPSCs were next seeded into the type I and II collagen functionalized scaffolds. Viable cells were observed in all functionalized scaffolds after ten days in culture ( Figure 6 ). Even with ECM functionalization, FPSCs appeared to align themselves in a direction parallel to the underlying scaffold pore structure ( Figure 6 ).
Coating with type II collagen was found to result in more homogenous tissue deposition within scaffolds seeded with FPSCs ( Figure 7G-I) . Similar results were observed with blended type II collagen scaffolds, although not as consistently as with coated scaffolds (Figure 7N and O). The specific types of collagen that filled the pores of the scaffolds also depended on the type of collagen they were functionalized with. The tissue that formed within C2C scaffolds stained more homogenously and intensely for type II collagen than all other groups, including uncoated and C1C scaffolds. Over 28 days of culture, these C2C scaffolds filled with a neo-cartilage tissue (Supplementary Figure S2) . The newly formed tissue within these C2C scaffolds stained weakly for type I collagen ( Figure 9M-O) . Small pockets of tissue staining positively for type II collagen were also observed in other scaffolds, including those functionalized with type I collagen (e.g. Figure 9E ; V-X; i).
Functionalizing anisotropic scaffolds with type II collagen results in the development of a more mechanically functional cartilaginous matrix
Tissues engineered with these collagen functionalized scaffolds were also analyzed biochemically to determine their DNA, sGAG, and collagen content, and mechanically tested to determine their equilibrium stiffness ( Figure 10 ). FPSC proliferation (as measured by DNA content) was greater in the collagen type II coated (C2C) scaffolds ( Figure 10A ). sGAG ( Figure 10B ) and collagen ( Figure 10C ) accumulation was greater in C2C compared to C1C scaffolds. Mechanically the C2C scaffolds were stiffer than both the control NC and C1C groups ( Figure 10D ).
FPSCs were also seeded for 4 weeks in scaffolds coated with chondroitin sulfate. While cells remained viable on these scaffolds, and the newly deposited tissue aligned in a direction parallel to pore architecture, overall levels of sGAG and collagen deposition were lower than in control scaffolds not functionalized with chondroitin sulfate (data not shown).
Discussion
The overall goal of this study was to develop a biomimetic, shape-memory alginate scaffold for cartilage tissue engineering applications. We sought to improve the mechanical properties of covalently crosslinked alginate scaffolds whilst simultaneously enhancing their chondroinductivity.
To this end the pore architecture was modified to mimic the aligned collagen network typically observed in load bearing cartilaginous tissues (e.g. the deep zone of articular cartilage or the outer region of the meniscus), and the scaffold was additionally functionalized with either type I (the main type of collagen in meniscal cartilage) or type II collagen (the main type of collagen in hyaline/articular cartilage). Porosity was modified using a directional freezing technique (34), enabling the creation of aligned pores within the alginate scaffold. These anisotropic scaffolds were stiffer than their counterparts with more isotropic pore geometries, and furthermore these geometrical features were found to direct stem cell migration, alignment and facilitated more homogenous neo-tissue deposition within the scaffold. Furthermore, the additional incorporation of type II collagen onto the surface of these scaffolds facilitated the formation of a hyaline cartilagelike tissue rich in sGAG and type II collagen. The tissues that formed within these type II collagen coated scaffold were also stiffer than those generated within scaffolds coated with type I collagen.
These findings open up the possibility of using anisotropic shape-memory scaffolds, functionalized with type II collagen extracted from articular cartilage, to regenerate cartilage defects.
A directional freeze-dying strategy was used to develop covalently crosslinked alginate scaffolds with anisotropic pore geometry, which improved the mechanical properties of the scaffold without compromising its shape-memory properties. It has previously been shown that introducing vertical pore alignment in chitosan-gelatin scaffolds improves their structural mechanical properties (32). A further advantage of modifying scaffold pore geometry is that it can provide structural cues to resident cells, which in turn can facilitate the engineering of complex tissues (31-34, 55, 56). In the context of articular cartilage regeneration, such an approach can potentially be leveraged to recapitulate the structural anisotropy of the tissue (32). Indeed, introducing pore alignment was found to enhance stem cell migration, proliferation and the deposition of cartilage-specific extracellular matrix within the scaffold. Furthermore, neo-tissue alignment was determined by the underlying scaffold architecture. Previous studies (57) have demonstrated that MSCs align and produce more mature collagen fibrils along the length of channels with widths of 25-100 μm (compared to channels of larger width), a comparable geometrical cue to the aligned pores (mean diameter = 32 μm) within our anisotropic scaffolds.
In spite of the promising features of the aligned shape-memory alginate scaffold (Align), they still suffered from a number of limitations, including poor cell attachment, limited cell proliferation and inhomogeneous neo-tissue deposition throughout the construct (23, 31) . This is likely due to the absence of binding sites within the unmodified alginate to facilitate cell-scaffold interactions, which reduces cell seeding efficiency that leads to heterogeneous tissue formation (23, 24, 31) mainly around the periphery of the scaffold. To overcome such a limitation it is possible to functionalize the alginate with ECM components such as fibronectin (31) and collagen 16 (24) . Motivated by previous studies (27) we functionalized these alginate scaffolds with either type I or type II collagen. In general, the alginate scaffolds retained their shape-memory capability following ECM functionalization, with a type II collagen coating found to increase the stiffness of the scaffold relative to uncoated controls. However this C2C scaffold also demonstrated a significant reduction in mechanical properties after cyclic loading, likely due to physical damage to the collagen coating during cyclic loading. Future studies will explore chemically modifying the alginate to promote chemical crosslinking with the coated collagen in an attempt to improve the long-term mechanical performance of the scaffold (58) . Another important finding of this study was the more efficient penetration and robust proliferation of stem cells within the type II compared to the type I collagen coated scaffolds. This finding is also in agreement with a previous study were chondrocytes were seeded into collagen-sGAG scaffolds containing different types of collagen (18) . They found that cells were mainly located at the periphery of type I collagen scaffolds, whilst type II collagen containing matrices supported a more homogeneous distribution of the cells throughout the scaffold (18) . The favorable chondrogenesis observed in such type II collagen devices may be mediated by specific integrin binding, which is crucial to maintain the chondrogenic phenotype and chondrocyte function (27, (63) (64) (65) (66) . Type II collagen can improve chondrogenesis through integrin interactions, which modulate the transforming growth factor signaling cascade critical for chondrogenesis (21, 67) . This collagen type is also known to improve cell attachment and chondrogenesis not only via integrins, but also with discoidin and annexin V receptors (21, 60, 66, 68, 69 We had initially hypothesized that functionalization with type I collagen would lead to the development of a more fibrocartilage tissue, however there was no evidence of greater levels of type I collagen deposition by FPSCs within these particular scaffolds. There was also evidence for type I collagen deposition within the type II collagen functionalized scaffolds, although overall more intense staining for type II collagen was observed, further supporting our contention that these scaffolds were supporting the development of a more hyaline-like cartilage rather than a fibrocartilaginous tissue. We have previously shown that FPSCs do produce both type I and type II collagen when stimulated with TGF-β3 (70, 71) , but when exposed to high levels of hydrostatic pressure mimicking that within articular cartilage, produce predominantly type II collagen (72) .
Future studies will explore if coating alginate scaffolds with a blend of both type I and type II collagen will be more beneficial for meniscal tissue engineering.
Conclusion
This study describes the development of an anisotropic, biomimetic, shape-memory scaffold for articular cartilage repair. It was demonstrated that functionalization with type II collagen enhances stem cell migration, proliferation and subsequent chondrogenesis. These findings support the concept that anisotropy and functionalization with tissue specific ECM coatings may overcome many of the limitations associated with current scaffolds for cartilage tissue engineering.
The appropriate design of such scaffolds may support the development of spatially complex tissues such as hyaline cartilage. Furthermore, the incorporation of architectural cues into such scaffolds may also enable their use for the regeneration of fibrocartilaginous tissues such as the meniscus. The shape-memory feature of this scaffold will also enable the use of such a device in minimally invasive surgeries, in addition to providing physical support to cells delivered to mechanically challenging joint environments.
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